project id: TCGA-KIRP; case submitter id: TCGA-B1-5398; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 73; days to birth: -26820; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 26820; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1251.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.7; preservation method: Unknown; shortest dimension: 0.2; sample id: 84ca8e25-e3b2-40da-8153-6c000ab6c677; sample submitter id: TCGA-B1-5398-01A; portion id: e515766b-a96c-421d-937a-f2e6b48436c0; portion submitter id: TCGA-B1-5398-01A-02; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0;